MACSF

COMMUNIQUÉS West-GlobeNewswire

SurgiBox Expands European Presence Through Strategic Partnership with Ondatec Medical in Türkiye
02/07/2025
CAMBRIDGE, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- SurgiBox, Inc., a pioneering medical technology company dedicated to bringing safe surgery to every patient, today announced a strategic partnership with Ondatec [...]
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
02/07/2025
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the [...]
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
02/07/2025
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With [...]
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
02/07/2025
1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, [...]
Cyclacel Pharmaceuticals Announces Stock Split
02/07/2025
BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today [...]
Athelas Launches AIR: The Only EHR with Fully Integrated Ambient Scribing, AI Agents, and Hands-Free RCM Automation
02/07/2025
Industry-leading EHR system now available for large physical therapy groups and SMBs, delivering real-time data access, streamlined billing, and AI-driven automation MOUNTAIN VIEW, Calif., July 02, 2025 (GLOBE NEWSWIRE [...]
Intuitive’s da Vinci 5 Surgical System Receives CE Mark
02/07/2025
Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally [...]
U.S. Oral Surgery Management Names Doug Drew CEO
02/07/2025
Richard Hall to Serve as Chairman of the Board IRVING, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) developed and implemented a succession plan earlier this year to ensure a smooth [...]
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
02/07/2025
US phase 1 trial of ‘2510 is expected to be initiated before the end of 2025 Anticipate ImmuneOnco sharing initial safety and efficacy results from phase 2 trial of ‘2510 + chemo in 1L NSCLC in the second half of 2025 [...]
The Ensign Group Purchases Skilled Nursing Facility in Texas
02/07/2025
SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Continues Growth in Idaho
02/07/2025
SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
02/07/2025
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host 1x1 meetings at [...]
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
02/07/2025
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) [...]
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
02/07/2025
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private [...]
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
02/07/2025
Combination treatment of mTNX-1700 (mTFF2-MSA fusion protein) with anti-PD1 antibody was associated with increased survival and decreased metastases in animal models of gastric cancer relative to anti-PD1 treatment [...]
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
02/07/2025
Pelthos plans to launch ZELSUVMI™ for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to [...]
Dr. Oetker monte sur scène avec Suprema, une nouvelle pizza surgelée sophistiquée célébrée par un spectacle d'opéra personnalisé
02/07/2025
Opéra personnalisé. Pizza de qualité supérieure. Des débuts spectaculaires au centre-ville de Toronto TORONTO, 02 juill. 2025 (GLOBE NEWSWIRE) -- Pour marquer le lancement de son produit le plus audacieux en plus de [...]
Dr. Oetker Takes the Stage with Suprema – A Sophisticated New Frozen Pizza Celebrated Through a Custom Opera Performance
02/07/2025
Custom opera. Premium pizza. A dramatic debut in downtown Toronto TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- To mark its boldest product launch in over two decades, Dr. Oetker Canada is introducing Suprema not just as a [...]
Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
02/07/2025
SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA ® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. [...]

Pages